FDA label
What is bumetanide used for?
The FDA-approved uses of bumetanide, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Bumetanide tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted bumetanide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Bumetanide, tablet
Indications and Usage, quoted from the label by NCS HealthCare of KY, LLC dba Vangard Labs (ANDA213942). Cross-references to other label sections are left out.
Bumetanide tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.
Almost equal diuretic response occurs after oral and parenteral administration of bumetanide. Therefore, if impaired gastrointestinal absorption is suspected or oral administration is not practical, bumetanide should be given by the intramuscular or intravenous route.
Successful treatment with bumetanide tablets following instances of allergic reactions to furosemide suggests a lack of cross-sensitivity.
Source: DailyMed label, set id fa4e5faf-c91a-457b-bd2b-14a9add51ac8, version 4, effective January 21, 2026. NDC 0615-8614, one of 87 listings for this product.
Bumetanide, injection
Indications and Usage, quoted from the label by Camber Pharmaceuticals, Inc. (ANDA218746). Cross-references to other label sections are left out.
Bumetanide Injection is indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.
Almost equal diuretic response occurs after oral and parenteral administration of bumetanide. Therefore, if impaired gastrointestinal absorption is suspected or oral administration is not practical, bumetanide should be given by the intramuscular or intravenous route.
Successful treatment with bumetanide following instances of allergic reactions to furosemide suggests a lack of cross-sensitivity.
Source: DailyMed label, set id 084b34ad-36ba-43bd-a43a-1f4b4da26d8f, version 1, effective April 14, 2025. NDC 31722-368, one of 24 listings for this product.
Questions
What is bumetanide used for?
The FDA label says: “Bumetanide tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.”
What drug class is bumetanide?
FDA lists bumetanide in the Loop Diuretic established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.